Mortality News and Research

RSS

‘Wisdom and fear’ lead 90% of U.S. seniors to covid vaccines

Amid the latest surge in covid-19 cases and hospitalizations, the United States on Tuesday hit a milestone that some thought was unattainable: 90% of people 65 and older are at least partly vaccinated against the disease.

4 Aug 2021

Inhibition of SARS-CoV-2 replication in vitro by Losartan

A new study explores the use of Losartan to provide protection against COVID-19 pathogenesis.

3 Aug 2021

Serum aldosterone concentrations provide a new measure for risk evaluation in HFpEF patients

Currently, patients with HFpEF have high risk of morbidity and mortality, but there is no effective measure for evaluating the prognosis.

3 Aug 2021

Study offers new insight on the global death toll of COVID-19 pandemic

New insight on the death toll of the COVID-19 pandemic worldwide has been published in the open-access eLife journal.

3 Aug 2021

What is the potential of microphysiological systems in COVID-19 research?

In a recently published review article in the journal Drug Discovery Today, scientists have described the utility of human-based microphysiological systems MPSs in understanding the pathophysiology of SARS-CoV-2 infection and developing effective therapeutic interventions. Moreover, they have described the establishment of a global working group to synchronize recent developments around MPSs and COVID-19 research.

3 Aug 2021

Study conducts systematic review of the pre- and asymptomatic SARS-CoV-2 transmission

Researchers at Oxford University, UK, have conducted a systematic review of the available studies to address the role of presymptomatic and asymptomatic transmission of SARS-CoV-2.

3 Aug 2021

Study shows efficacy of Pfizer-BioNTech and Moderna vaccines against SARS-CoV-2 delta variant

Researchers in Singapore have conducted a study showing that the messenger RNA- (mRNA) based coronavirus disease 2019 (COVID-19) vaccines developed by Pfizer-BioNTech and Moderna are highly effective at protecting against symptomatic and severe disease following infection with the rapidly spreading B.1.617.2 (delta) variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

2 Aug 2021

New model can help clinicians to predict 40-day mortality risk in hospitalized COVID-19 patients

Researchers from Hackensack Meridian University Medical Center and Berry Consultants, LLC, Austin, Texas have developed a new model to help clinicians predict the risk of death within 40 days in patients who are hospitalized with COVID-19 infection.

2 Aug 2021

Study finds racial and ethnic disparities in post-operative breast cancer surgery outcomes

Breast cancer is the most commonly diagnosed cancer among American women and surgery is a primary treatment for these women. Among women receiving surgery, up to 13% will have a post-operative visit to an emergency department, according to recent research.

2 Aug 2021

Older adults with prior SARS-CoV-2 infection benefit from two doses of Pfizer/BioNTech vaccine

The study by researchers from the Ministry of Health, Madrid, Spain, published in the Center of Disease Control and Prevention’s journal Emerging Infectious Diseases, suggests that long-term care facility residents with prior SARS-CoV-2 infection benefit from full vaccination with the Pfizer/BioNTech (BNT162b2) vaccine.

2 Aug 2021

Risk of venous thrombosis is higher in SARS-CoV-2 infection than vaccination

A study has revealed that adenovirus vector and mRNA-COVID-19 vaccines are associated with an increased risk of thromboembolism and thrombocytopenia.

1 Aug 2021

Fellowship directors endorse the need for increasing diversity in cardiology

Underrepresented minorities remain few in number among practicing cardiologists and across cardiology fellowship training programs in the United States, with fellowship directors agreeing that increased diversity is needed in the field and is particularly necessary within graduate medical education cardiology fellowship training programs.

30 Jul 2021

In-silico prediction of effective drug combinations for the treatment of SARS-CoV-2 infection

A new study published on the bioRxiv preprint server has developed the first computational model, i.e., a signaling network model, that can predict effective repurposed drug combinations to treat different phases of COVID-19 disease. This study has focused on identifying drugs for the treatment of early- and late-stage severe disease.

30 Jul 2021

Streptococcus pneumoniae modulates host immunity to SARS-CoV-2

Scientists from the UK and US have recently investigated immunological consequences of secondary Streptococcus pneumoniae (S. pneumoniae) infection in coronavirus disease 2019 (COVID-19) patients.

29 Jul 2021

Study quantifies the mortality cost of carbon emissions

A just-published study coins a new metric: the "mortality cost of carbon." That is, how many future lives will be lost--or saved--depending on whether we increase or decrease our current carbon emissions.

29 Jul 2021

Is it possible to identify pre-symptomatic and asymptomatic COVID-19 clinically?

The COVID-19 pandemic has severely impacted morbidity and mortality in nursing home residents across the world. Earlier detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) may help better mitigate the risk of viral transmission. As both pre-symptomatic and asymptomatic transmission is common in these outbreaks, screening for threshold temperatures of 38°C or higher could miss timely detection in most infected people.

29 Jul 2021

Study explores why COVID-19 lockdown does not work in Africa as first pandemic response

In an African pandemic it is more productive to consider lockdowns, after using other non-medical measures first, Especially in countries with high levels of poverty and corruption, says Prof Nicholas Ngepah, a Professor of Economics at the University of Johannesburg in South Africa.

28 Jul 2021

People with OSA have greater risk of sudden death and cardiovascular conditions

A study by Penn State College of Medicine researchers reveals that people living with obstructive sleep apnea (OSA), a condition that occurs when a person's airway becomes blocked while they are asleep, are twice as likely to experience sudden death compared to people living without OSA.

28 Jul 2021

Systematic review explores the effects of ivermectin in preventing and treating COVID-19

Ivermectin, a drug used to treat parasites such as scabies in humans and intestinal helminths in cattle, was screened in 2020 for activity against COVID-19. Laboratory tests suggested a weak effect on SARS-CoV-2 virus in a test tube but did not seem feasible in humans as the doses needed would be large.

28 Jul 2021

Immunity to SARS-CoV-2 in renal transplant and dialysis patients using Pfizer/BioNTech and Moderna vaccines

A study analyzes the immune responses of medical personnel, as well as immunocompromised DP and immunosuppressed KTR patients.

27 Jul 2021

Mortality News and Research

‘Wisdom and fear’ lead 90% of U.S. seniors to covid vaccines

Inhibition of SARS-CoV-2 replication in vitro by Losartan

Serum aldosterone concentrations provide a new measure for risk evaluation in HFpEF patients

Study offers new insight on the global death toll of COVID-19 pandemic

What is the potential of microphysiological systems in COVID-19 research?

Study conducts systematic review of the pre- and asymptomatic SARS-CoV-2 transmission

Study shows efficacy of Pfizer-BioNTech and Moderna vaccines against SARS-CoV-2 delta variant

New model can help clinicians to predict 40-day mortality risk in hospitalized COVID-19 patients

Study finds racial and ethnic disparities in post-operative breast cancer surgery outcomes

Older adults with prior SARS-CoV-2 infection benefit from two doses of Pfizer/BioNTech vaccine

Risk of venous thrombosis is higher in SARS-CoV-2 infection than vaccination

Fellowship directors endorse the need for increasing diversity in cardiology

In-silico prediction of effective drug combinations for the treatment of SARS-CoV-2 infection

Streptococcus pneumoniae modulates host immunity to SARS-CoV-2

Study quantifies the mortality cost of carbon emissions

Is it possible to identify pre-symptomatic and asymptomatic COVID-19 clinically?

Study explores why COVID-19 lockdown does not work in Africa as first pandemic response

People with OSA have greater risk of sudden death and cardiovascular conditions

Systematic review explores the effects of ivermectin in preventing and treating COVID-19

Immunity to SARS-CoV-2 in renal transplant and dialysis patients using Pfizer/BioNTech and Moderna vaccines

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Exploring the G:Box and for high-quality imaging

Latest News